The effect of verbalization strategy on wisconsin card sorting testperformance in schizophrenic patients receiving classical or atypical antipsychotics

Rossi, Alessandro; Daneluzzo, Enrico; Tomassini, Annarita; Struglia, Francesca; Cavallaro, Roberto; Smeraldi, Enrico; Stratta, Paolo
January 2006
BMC Psychiatry;2006, Vol. 6, p3
Academic Journal
Background: A number of reports showed en encouraging remediation in some patients' executive deficits thanks to the use of 'information processing strategies'. Moreover the impact of antipsychotics on cognitive functions of the schizophrenics is an important issue, especially if an integrated psychosocial treatment is needed. The aim of this paper is to evaluate different executive performance and response to verbalization, a strategy of the Wisconsin Card Sorting Test (WCST) remediation, in subjects on classical vs atypical antipsychotic (AP) treatment. Methods: Sixty-three schizophrenic subjects undertook the WCST under standard and modified (verbalization) administration. Subjects were stratified by the kind of WCST response (i.e. good, poor and remediable) and AP treatment (i.e. atypical vs. classical). Results: Subjects on atypical APs showed a better performance than those on classical ones. More poor performers who did not remediate were seen in the sample with classical Aps while subjects who remediated the performance were seen in the subgroup with atypical APs only. An increase of perseverative and total errors was seen in poor performers subjects on classical APs. Conclusion: Subjects on atypicals showed a better cognitive pattern in terms of WCST performance. Since the naturalistic assignment of medication we cannot draw conclusions about its effect on cognitive performance and its interaction with cognitive remediation potential. However the data lead us to hypothesize that subjects with potential room for remediation did so with the atypical APs.


Related Articles

  • Effects of long-term treatment with antipsychotics on serum leptin levels. Herrán, Andrés; García-Unzueta, María Teresa; Amado, José Antonio; de la Maza, María Teresa; Álvarez, Concepción; Vázquez-Barquero, José Luis; Herrán, A; García-Unzueta, M T; Amado, J A; de La Maza, M T; Alvarez, C; Vázquez-Barquero, J L // British Journal of Psychiatry;Jul2001, Vol. 179, p59 

    Background: Abnormal regulation of the adipocyte-derived hormone leptin could play a role in body weight gain induced by antipsychotics.Aims: To study the effects of long-term antipsychotic treatment on leptin levels in patients with schizophrenia.Method:...

  • The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia. McCabe, Rosemarie; Bullenkamp, Jens; Hansson, Lars; Lauber, Christoph; Martinez-Leal, Rafael; Rössler, Wulf; Salize, Hans Joachim; Svensson, Bengt; Torres-Gonzalez, Francisco; van den Brink, Rob; Wiersma, Durk; Priebe, Stefan // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Objective: Previous research has shown that a better therapeutic relationship (TR) predicts more positive attitudes towards antipsychotic medication, but did not address whether it is also linked with actual adherence. This study investigated whether the TR is associated with adherence to...

  • The clinical correlates of neurological soft signs in chronic schizophrenia. King, D. J.; Wilson, A.; Cooper, S. J.; Waddington, J. L. // British Journal of Psychiatry;Jun91, Vol. 158, p770 

    Among 16 chronic schizophrenic in-patients, all had at least one neurological soft sign (NSS), and 6 (40%) had definite neurodysfunction. NSS and TD scores were highly intercorrelated, and NSS were significantly correlated with neuroleptic drug exposure. NSS correlated positively with both...

  • Mapping the pathophysiology of schizophrenia: interactions between multiple cellular pathways. Chao Deng; Dean, Brian // Frontiers in Cellular Neuroscience;Nov2013, Vol. 7, p80 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the search for biomarkers for psychosis and schizophrenia, the features of polysialic acid, and the animal model for schizophrania.

  • The Effect of Fluphenazine Enanthate on Chronic and Relapsing Schizophrenia. Lowther, John // British Journal of Psychiatry;Jun69, Vol. 115 Issue 523, p691 

    The article examines the effect of fluphenazine enanthate on chronic and relapsing schizophrenia. According to the author, fluphenazine enanthate is used in conjunction with an active rehabilitation program to schizopherinic subjects. Treatment is set while the patient is in the hospital, and...

  • Review: in people with schizophrenia, lithium is ineffective as sole therapy, while evidence on augmenting antipsychotics with lithium is inconclusive. Bender, Stefan; Dittmann-Bakar, Alexandra // Evidence Based Mental Health;Nov2004, Vol. 7 Issue 4, p104 

    The article presents an answer to the clinical question related to the role of antipsychotic drugs in the treatment of schizophrenia. Treatment of schizophrenia with lithium alone is not effective. Results of lithium augmentation arc inconclusive. Any benefit may be outweighed by a lower...

  • Caution advised with atypicals. Polak, Monika // GP: General Practitioner;8/30/2004, p15 

    Concerns about the side-effects of atypical antipsychotic drugs have been raised by a Consumers' Association review. The authors concluded that more research is needed into the potentially harmful side-effects of the drugs, so that doctors can assess which one will suit each patient best. NICE...

  • Older and newer antipsychotics compared in large trial. Guthrie, Ellen Whipple // Pharmacy Today;Dec2005, Vol. 11 Issue 12, p6 

    The article presents information on the antipsychotic medications needed to treat schizophrenia. Though this medications do not cure the disease, but they are essential for its management. A study was conducted by the Clinical Antipsychotic Trials of Intervention Effectiveness, which compared...

  • The distinction of positive and negative symptoms. The failure of a two-dimensional model. Arndt, Stephan; Alliger, Randall J.; Andreasen, Nancy C.; Arndt, S; Alliger, R J; Andreasen, N C // British Journal of Psychiatry;Mar91, Vol. 158, p317 

    The distinction of positive and negative symptoms in describing schizophrenic patients has become popular. It presupposes that symptoms cluster in two dimensions, fitting together not only theoretically but empirically. Factor analysis of three published studies of 93, 62 and 52 schizophrenic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics